Status: current, Defined. Date: 31-Dec 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2628901000168110 | Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2628931000168115 | Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) (fluorescein sodium 1.25 mg / 0.5 mL + lidocaine hydrochloride monohydrate 20 mg / 0.5 mL) eye drops, 0.5 mL unit dose (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | has manufactured dose form | eye drops | true | Inferred relationship | Some | ||
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | Is a | Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) | true | Inferred relationship | Some | ||
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | Is a | lidocaine hydrochloride monohydrate 4% + fluorescein sodium 0.25% eye drops, unit dose | true | Inferred relationship | Some | ||
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | has manufactured dose form | eye drops solution | false | Inferred relationship | Some | ||
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | has unit of use | unit dose | true | Inferred relationship | Some | 1215704253 | |
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | has Australian BoSS | fluorescein sodium | true | Inferred relationship | Some | 1215704252 | |
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | has intended active ingredient | fluorescein | true | Inferred relationship | Some | 1215704252 | |
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | has Australian BoSS | lidocaine hydrochloride monohydrate | true | Inferred relationship | Some | 613021817 | |
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | has intended active ingredient | lidocaine | true | Inferred relationship | Some | 613021817 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 20 x 0.5 mL unit doses | has TPUU | True | Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | Inferred relationship | Some | 1 |
| Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) (fluorescein sodium 1.25 mg / 0.5 mL + lidocaine hydrochloride monohydrate 20 mg / 0.5 mL) eye drops, 20 x 0.5 mL unit doses, tube (containered trade product pack) | has TPUU | True | Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 0.5 mL unit dose | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR